As a member of the PKC family, increased PKCδ activation has been observed in the liver tissue of NASH mice and the human hepatic cell line L02 treated with PA (Lai et al., 2017; Koh et al., 2021). The gene discussed is PRRT2; the disease is metabolic dysfunction-associated steatohepatitis.